Passa al contenuto
Merck

Vai a

1342037

USP

Insulin aspart

United States Pharmacopeia (USP) Reference Standard

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
A voi/SKUDisponibilitàPrezzo

Informazioni su questo articolo

Formula empirica (notazione di Hill):
C256H381N65O79S6
Numero CAS:
Peso molecolare:
5825.54
NACRES:
NA.24
UNSPSC Code:
41116107
Prezzi e disponibilità al momento non sono disponibili
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


grade

pharmaceutical primary standard

agency

USP

API family

insulin

form

solid

manufacturer/tradename

USP

application(s)

USP Biologics
pharmaceutical (small molecule)
pharmaceutical

General description

Insulin Aspart is a rapid-acting insulin analog produced by recombinant DNA technology. It differs from human insulin by a single amino acid substitution, enhancing its absorption rate. This modification allows for improved postprandial glucose control in diabetic patients.

The USP biologics proteins category provides critical standards and reference materials necessary for the development and manufacturing of therapeutic proteins. These proteins, which can be naturally derived or genetically engineered, are essential in treating various diseases and conditions, ensuring that they meet quality, safety, and efficacy standards.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

Application

Insulin aspart USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Insulin Aspart Injection

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.
This product is part of the USP Biologics program.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
Y00003491342321I0310000
USP

USP

1342037

Insulin aspart

vibrant-m

Y0000349

Insulin aspart

USP

USP

1342321

Insulin lispro

vibrant-m

I0310000

Insulina

manufacturer/tradename

USP

manufacturer/tradename

EDQM

manufacturer/tradename

USP

manufacturer/tradename

EDQM

application(s)

USP Biologics
pharmaceutical (small molecule)
pharmaceutical

application(s)

pharmaceutical (small molecule)

application(s)

USP Biologics
pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

form

solid

form

-

form

crystalline powder

form

-

API family

insulin

API family

insulin

API family

insulin

API family

insulin


Classe di stoccaggio

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti



Questions

Reviews

No rating value

Active Filters